Z300 (Caprelsa 300 mg)
Generic Name: vandetanib
Pill imprint Z300 has been identified as Caprelsa 300 mg.
Caprelsa is used in the treatment of thyroid cancer and belongs to the drug classes EGFR inhibitors, multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Caprelsa 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- vandetanib
- Imprint:
- Z300
- Strength:
- 300 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- EGFR inhibitors
Multikinase inhibitors
VEGF/VEGFR inhibitors - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Genzyme Corporation
More about Caprelsa (vandetanib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: EGFR inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
